More than 2 million over the world suffer from Multiple sclerosis (MS). It attacks the central nervous system and eventually renders most patients disabled. Although there is currently no cure, a breakthrough finding from a Tel Aviv University scientist and physician may lead to earlier diagnosis, more effective intervention, and perhaps even a cure for the autoimmune disease.
35 seconds. That's how fast caregivers can get blood gas results on the ABL90 FLEX, Radiometer's next-generation, cassette-based analyzer. The unmatched short time to results enables caregivers to spend less time on testing and more on patient care. The ABL90 FLEX measures 17 parameters, including blood gas, electrolytes, metabolites and CO-oximetry from just 65μL of whole blood.
A study published online today in the journal Genome Research offers surprising new clues into the genomic complexity of the giant Mimivirus, the largest known virus in the world. Previous studies have shown that unlike most viruses, the Mimivirus has more genes than many bacteria and performs functions that normally occur only in cellular organisms. The results of the most recent study, led by a…
Researchers from University Hospital in Umea, Sweden, have identified several cytokines, cytokine-related factors, and chemokines that increase significantly prior to rheumatoid arthritis (RA) disease onset. These findings confirm those of earlier studies which suggest that the risk of developing RA can be predicted and disease progression may be prevented. Complete findings of this study are…
Inverness Medical has produced the Clearview Malaria rapid test range for rapid in vitro detection of malarial antigens in whole blood. The test comes in two different formats: Clearview Malaria P.f. is a qualitative test for detecting the most common, virulent and deadly malaria causing parasite Plasmodium falciparum; Clearview Malaria Combo detects and differentiates between the Plasmodium…
Organised by the Syndicat des Biologistes (SDB) the annual meeting in November, under the auspices of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the European Federation of Clinical Chemistry and Laboratory Medicine (EFCC) and the French Society of Clinical Biology (SFBC), the Journees Internationales de Biologie (JIB) aims to meet the needs of the 10,700…
Hôpital, Patients, Santé et Territories (HPST), a new hospital reform bill, was passed by the French Government and became law in July 2009. While directly related to hospitals it also places new importance on health from the patients’ perspective outside the hospital. Importantly for laboratory medicine, the act makes accreditation for both public and private laboratories obligatory rather…
Whereas, in the past, the diagnoses of infectious diseases focused on antibody detection, more recently laboratories aim to identify the agent itself, using the invaluable PCR (polymerase chain reaction) test. We asked Prof Beatus Ofenloch-Hähnle, head of Reagent and System Development Immunology, at Roche Professional Diagnostics, and Benjamin Lilienfeld, Global Product Manager for Infectious…
The UK’s Babraham Institute, which conducts biomedical research, has established a ‘high throughput’ epigenomics sequencing facility to improve understanding of healthier ageing.
The new Olympus DP21 digital microscopy camera for high-definition (HD) image capture is suitable for use in life science and materials microscopy. The 2.11 megapixel stand-alone camera allows easy observation, focusing and framing, while enabling the smooth display of real-time 1600x1200 (UXGA) images, the manufacturer reports.
A child's blood pressure, body mass index, blood glucose level and other laboratory tests and simple office measures may predict the risk of developing type 2 diabetes nine and 26 years later, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of, one of the JAMA/Archives journals.
Clinical laboratory scientists, the medical technologists of the 21st century, are not only enjoying a rapidly expanding role in clinical work but are also increasingly undertaking non-clinical duties such as consultation, quality assurance, laboratory management, professional advocacy and education.
The newest laboratory system from Ortho Clinical Diagnostics is a big success: 32 VITROS 3600 immunoassay systems are going to be used in 15 of a total of 21 blood banks in Poland in the future. They will enable roughly 800,000 blood tests to be carried out each year. This next-generation diagnosis platform is based on VITROS technologies, the best in the world, thus meeting the demands of modern…
Marking its 10th year of participating in Medica, Mindray Medical International introduced in Europe four new products for its growing portolfio of in vitro diagnostics. Three five-part hematology analyzers were featured front-and-center at the company's stand in Hall 03 covering the range of laboratory needs from the manual BC-5300, to the mid-line automated BC-5380 to the top of the line BC…
Roche Diagnostics presents nine new products at this year’s Medica. Three of them were the focal point of today’s launch event at which customers and visitors had a chance to find out more about state-of-the-art systems for PCR and high throughput laboratories.
Today testing of patients at the point of care (POC) accounts for 25% of all testing, and these portable assays are increasing their penetration into medical practice at rapid rate of 12% each year. Yet along with the growth comes an increasing risk of errors that adversely affect quality of clinical decision-making and patient safety.
As concern over the potential mutation of the latest form of influenza virus continues to vex governments and their healthcare organisations, WHO 2009 data has shown that acute respiratory infections, influenza and respiratory syncitial virus (RSV) epidemics coincide with epidemics of S. pneumoniae. In fact, half or more of flu-associated mortality in the 1918-1919 Spanish Flu epidemic is…
It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient. Researchers at the Heinz Nixdorf Chair for Medical Electronics at the Technische Universitaet Muenchen (TUM) have developed a new test process for cancer drugs. With the help of microchips, they can establish in the laboratory whether a…
Krebs kann sich in jeder Stelle des Körpers bilden. Selbst in Muskeln, Fett- und Nervengewebe können Tumore entstehen. Rund 4.000 Menschen in Deutschland erkranken jährlich an Weichteiltumoren. Damit zählen die sogenannten Sarkome zu den seltenen Krebserkrankungen und werden dadurch oft nur schwer erkannt.
A global vaccination programme against human papilloma virus (HPV), to include boys as well as girls, could lead to eradication of the virus and virtual disappearance of cervical cancer, predicted Nobel Prize winner, Professor Harald zur Hausen, after delivering the key-note lecture at the 16th International Meeting of the European Society of Gynaecological Oncology (ESGO) in Belgrade, Serbia,…
Colorectal cancer occurs in approximately one in every 17 people during their lifetime and is the second leading cause of cancer death in Europe. Two new blood tests could aid in the early identification of patients with gastrointestinal (GI) cancers. The tests will make GI cancer detection simpler, cost-effective, and more acceptable to patients than current methods, the researchers say.
Researchers around the globe are studying whether a genomic test, developed with micro-array technology, is superior to traditional methods in assessing aggressive breast cancer, and therefore could spare a considerable percentage of women from the onslaught of chemotherapy The Breast International Group (BIG) in Brussels, Belgium, manages TRANSBIG, an international network created to avoid…
By David Loshak
This year's AACC, held in conjunction with the Canadian Society for Clinical Chemists, and the Annual Meeting of the American Society for Clinical Laboratory Science, featured around 200 educational sessions and drew in over 18,000 delegates and exhibitors from almost 100 countries.
PSA-Kritiker PD Dr. rer. nat. Hans-Hermann Dubben und DGU-Generalsekretär Prof. Dr. Michael Stöckle suchten das Gespräch Selten wurde zwischen den Kritikern und den Befürwortern der PSA-gestützten Früherkennung des Prostatakarzinoms so hart diskutiert. Die Veröffentlichung der randomisierten Studien zum PSA-Screening aus Europa (ERSPC-Studie) und den USA (PLCO-Screeningstudie) hatte in…